Skip to main content

and
  1. No Access

    Article

    Amlodipin-Intoxikation mit reanimationsbedürftiger Asystolie

    There is little data about intoxications with high doses of amlodipine, especially about relevant bradycardias.

    Dr. F. Wimmer, R. Lenzhofer in Intensivmedizin und Notfallmedizin (2003)

  2. No Access

    Article

    Abgeschlossene und derzeit laufende adjuvante Therapieprotokolle bei Patientinnen mit operablem Mammakarzinom (II)

    Grundlagen: Seit 1984 wurden 4336 Patientinnen mit Mammakarzinom österreichweit in adjuvante Therapiestudien eingebracht.

    Prof. Dr. R. Jakesz, M. Gnant, Marianne Schmid, H. Samonigg in Acta chirurgica Austriaca (1997)

  3. No Access

    Article

    Acute jejunal ileus in intestinal lymphangiectasia

    A 26-year-old patient presented with epigastric pain of sudden onset and severe puffy swelling of both legs and forearms. An irregularly shaped nodular filling defect on selective jejunal films, severe hypopro...

    R. Lenzhofer, M. Lindner, A. Moser, J. Berger, C. Schuschnigg in The clinical investigator (1993)

  4. No Access

    Article

    Pamidronat in der Behandlung der tumorassoziierten Hypercalcämie

    After a 48-hour rehydration period 28 of 31 patients with cancer-associated hypercalcemia (serum calcium ≥2.8 mmol/1) were treated intravenously with the bisphosphonate pamidronate. In three patients fluid rep...

    M. Pecherstorfer, S. Janisch, C. Marosi, C. Wogritsch, C. Bosse in Klinische Wochenschrift (1991)

  5. No Access

    Article

    Abgeschlossene und derzeit laufende adjuvante Therapieprotokolle bei Patienten mit operablem Mammakarzinom

    In der 1983 gegründeten Cooperativen Studiengruppe Mammakarzinom (COSTMA) argeiten derzeit etwa 50 onkologische Abteilungen Österreichs zusammen. Durch die Ausgewogenheit chirurgischer, gynäkologischer und int...

    Prof. Dr R. Jakesz, H. Hausmaninger, D. Depisch, E. Kubista in Acta Chirurgica Austriaca (1991)

  6. No Access

    Article

    Indication of doxorubicin cardiotoxicity by impairment of 131I-pIPPA utilization

    The present study was designed to evaluate if doxorubicin (D) can impair myocardial fatty acid utilization. To this end we studied the myocardial utilization of 131I-pIPPA in untreated (Co, n=6) and D (20 mg/kg i...

    R. Lenzhofer, R. Dudczak in European Journal of Nuclear Medicine (1986)

  7. No Access

    Article

    Plasmapheresis in the management of psoriasis

    R. Schuster, R. Lenzhofer, M. Raff in Archives of Dermatological Research (1985)

  8. No Access

    Article

    Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment

    In two groups of female patients with metastatic breast cancer who had all been pretreated with doxorubicin (350 mg/m2), acute cardiac effects following i.v. doxorubicin bolus injection (60 mg/m2) were recorded o...

    R. Lenzhofer, U. Ganzinger, H. Rameis in Journal of Cancer Research and Clinical On… (1983)

  9. No Access

    Article

    Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy

    Ninety-eight female patients (mean age 54 years) who underwent doxorubicin therapy because of metastatic breast cancer were submitted to radionuclide angiography at rest. Left ventricular ejection fractions (L...

    R. Lenzhofer, R. Dudczak, G. Gumhold in Journal of Cancer Research and Clinical On… (1983)

  10. No Access

    Article

    Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substances

    The influence of antioxidative substances on doxorubicin-induced cardiac toxicity was studied in C 57 BL mice. Tocopherol (500 mg/kg), glutathione (1000 mg/kg), cysteamine (15 mg/kg) and L-cysteine (1000 mg/kg...

    R. Lenzhofer, D. Magometschnigg, R. Dudczak, C. Cerni, C. Bolebruch in Experientia (1983)

  11. No Access

    Chapter and Conference Paper

    Hämatologie/Onkologie

    Kolonienstimulierende Faktoren („Colony Stimulating Factors, CSF“) stimulieren in vitro das Wachstum von myeloisch determinierten Stammzellen („Colony Forming Units, CFUC“). Von den Blutzellen sind es ausschließl...

    W. Hinterberger, P. Bettelheim in Verhandlungen der Deutschen Gesellschaft f… (1982)

  12. No Access

    Article

    Failure of somatostatin to influence experimental tumor cell growth in vivo and in vitro

    The influence of somatostatin on tumor cell growth was studied in vivo in mice (sarcoma 180 ascites tumor and Lewis lung tumor) and in vitro on nontransformed and polyoma-transformed cell lines. 4 or 20 μg/100...

    R. Lenzhofer, C. Cerni, I. Fröhlich, J. Prager, H. Pointner in Experientia (1981)

  13. No Access

    Chapter and Conference Paper

    In vitro-Untersuchungen mit menschlichem Transferfaktor

    Die Fähigkeit des menschlichen Transferfaktors, Mechanismen der zellulären Immunität auf einen nicht-sensibilisierten Empfänger zu übertragen, wurde seit der Erstveröffentli-chung durch Lawrence (1963) von vie...

    H. Rainer, K. Moser, R. Lenzhofer, P. Bettelheim in 84. Kongreß (1978)